The present study demonstrates that amygdalar metabolic activity is increased under fasting hyperglycemic condition or in patients with a history of CAD, and reduction of amygdalar metabolic activity is independently associated with baseline serum PEDF and ΔPEDF in patients with T2DM. The gene discussed is SERPINF1; the disease is type 2 diabetes mellitus.